Quantinuum IPO Valued Above $15B as UBS Sets $78 Target and Jefferies Issues Buy
QNT•On June 29, UBS raised Quantinuum’s price target to $78, implying a 3.22% upside from its $75.57 trading level. Jefferies initiated coverage with a Buy rating after the firm’s Nasdaq IPO valued it at over $15 billion.
1. UBS Raises Price Target to $78
On June 29, a UBS analyst increased Quantinuum’s one-year price target to $78, indicating a 3.22% upside from the $75.57 trading level. The revision reflects surging demand for quantum computing solutions driven by recent government directives and AI-driven compute requirements.
2. Jefferies Initiates Buy Rating Post-IPO
Jefferies began coverage of Quantinuum with a Buy rating following its Nasdaq debut, which valued the company at over $15 billion. The firm highlighted Quantinuum’s full-stack hardware and software model and its advanced trapped-ion technology as key competitive differentiators.
3. Commercialization Challenges and Valuation Risks
Despite strong analyst endorsements, Quantinuum faces hurdles in commercializing its quantum systems and reducing error rates inherent in current machines. Investors remain cautious about the high post-IPO valuation and the firm’s ability to execute on its ambitious growth strategy.
